Contact information
Research groups
Colleges
Brian Angus
BSc, MBChB, DTM&H, FRCP, MD, FFTM
Professor of Practice, Medical Education and Reader in Infectious Diseases
- Graduate Studies Director
- Reader in Infectious Diseases
- Associate Professor
- Clinical Tutor in Medicine
Professor Brian Angus is the Director of the Oxford Centre for Clinical Tropical Medicine and Global Health. He joined the Nuffield Department of Clinical Medicine in 1993 and originally worked in Thailand and Ghana studying pharmacokinetics in severe malaria and melioidosis. His research focus is now on clinical trials and vaccine development in COVID, malaria, influenza, HIV, Chronic Fatigue Syndrome, and enteric fever. He is Clinical Tutor in Medicine and Associate Professor and Reader in Infectious Diseases at the University of Oxford. He holds an honorary Senior Clinical Scientist tltle at the MRC CTU.
Recent publications
-
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
Venkatraman N. et al, (2025), The Lancet Microbe, 100868 - 100868
-
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.
Venkatraman N. et al, (2025), The Lancet. Microbe
-
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.
Singh K. et al, (2024), The Journal of infectious diseases, 230, 624 - 634
-
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV.
Mccabe L. et al, (2024), AIDS (London, England)
-
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Michael BD. et al, (2024), Nature Communications, 15